CN105039596B - A kind of kit and its application for being used to detect parainfluenza virus - Google Patents
A kind of kit and its application for being used to detect parainfluenza virus Download PDFInfo
- Publication number
- CN105039596B CN105039596B CN201510468275.2A CN201510468275A CN105039596B CN 105039596 B CN105039596 B CN 105039596B CN 201510468275 A CN201510468275 A CN 201510468275A CN 105039596 B CN105039596 B CN 105039596B
- Authority
- CN
- China
- Prior art keywords
- sequence
- probe
- primer pair
- parainfluenza virus
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000002606 Paramyxoviridae Infections Diseases 0.000 title claims abstract description 70
- 241000700605 Viruses Species 0.000 title claims abstract description 69
- 239000000523 sample Substances 0.000 claims description 81
- 230000003321 amplification Effects 0.000 claims description 51
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 51
- 238000006243 chemical reaction Methods 0.000 claims description 45
- 239000000243 solution Substances 0.000 claims description 22
- 102000004190 Enzymes Human genes 0.000 claims description 12
- 108090000790 Enzymes Proteins 0.000 claims description 12
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000007853 buffer solution Substances 0.000 claims description 10
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000013642 negative control Substances 0.000 claims description 7
- 102100034343 Integrase Human genes 0.000 claims description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 claims description 5
- 108091028733 RNTP Proteins 0.000 claims description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 3
- 101710203526 Integrase Proteins 0.000 claims description 3
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical class [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 claims description 3
- 102000009609 Pyrophosphatases Human genes 0.000 claims description 3
- 108010009413 Pyrophosphatases Proteins 0.000 claims description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 3
- 238000010791 quenching Methods 0.000 claims description 3
- 230000000171 quenching effect Effects 0.000 claims description 3
- 239000003161 ribonuclease inhibitor Substances 0.000 claims description 3
- 125000006853 reporter group Chemical group 0.000 claims description 2
- 238000001514 detection method Methods 0.000 abstract description 20
- 238000000034 method Methods 0.000 abstract description 17
- 238000012360 testing method Methods 0.000 abstract description 17
- 238000012544 monitoring process Methods 0.000 abstract description 8
- 230000003612 virological effect Effects 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 230000004907 flux Effects 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 35
- 102000053602 DNA Human genes 0.000 description 32
- 238000001179 sorption measurement Methods 0.000 description 26
- 239000013612 plasmid Substances 0.000 description 19
- 108090000623 proteins and genes Proteins 0.000 description 13
- 150000007523 nucleic acids Chemical class 0.000 description 10
- 238000003757 reverse transcription PCR Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000005119 centrifugation Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 102000039446 nucleic acids Human genes 0.000 description 9
- 108020004707 nucleic acids Proteins 0.000 description 9
- 108020004682 Single-Stranded DNA Proteins 0.000 description 7
- 239000011259 mixed solution Substances 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 238000013518 transcription Methods 0.000 description 6
- 230000035897 transcription Effects 0.000 description 6
- 206010006451 bronchitis Diseases 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 229920000936 Agarose Polymers 0.000 description 4
- 239000013614 RNA sample Substances 0.000 description 4
- 230000009514 concussion Effects 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000002773 nucleotide Substances 0.000 description 4
- 125000003729 nucleotide group Chemical group 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000012925 reference material Substances 0.000 description 4
- 108700039887 Essential Genes Proteins 0.000 description 3
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 3
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 3
- 238000011901 isothermal amplification Methods 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 206010035664 Pneumonia Diseases 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 201000010549 croup Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 101150072531 10 gene Proteins 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 208000030500 lower respiratory tract disease Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 208000011479 upper respiratory tract disease Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of kit and its application for being used to detect parainfluenza virus.Contain the primer pair group for being used for detecting parainfluenza virus in kit provided by the present invention, be made up of 3 primer pairs, its sequence is sequence 16 in sequence table.Kit provided by the invention supports high flux, parainfluenza virus infection can quickly and accurately be detected, for clinic, the testing result that 3 kinds of viral indexs can be obtained in 1 hour is not only faster than the real time fluorescence quantifying PCR method more generally used at present, and also significant for the treatment of quick auxiliary direction and medication.Meanwhile the detection of multi objective can be used for regional epidemiological survey and epidemic situation monitoring, to study popularity of the parainfluenza virus infection in China.
Description
Technical field
The invention belongs to nucleic acid amplification technologies field, is related to a kind of kit for being used to detect parainfluenza virus and its answers
With.
Background technology
Human parainfluenza virus (HPIVs) are one kind virus for often causing children's ALRI, and its is pathogenic only
Inferior to Respiratory Syncytial Virus(RSV) (RSV).As RSV, human parainfluenza virus can cause the upper respiratory tract sense of recurrent exerbation
Contaminate (such as catch a cold and have a sore throat).It can also cause lower respiratory illness (such as pneumonia, the bronchitis and thin of serious repeated infection
Bronchitis), particularly in the elderly and immune deficiency crowd.
Human parainfluenza virus can be divided into 4 types (I types to IV types) from serology.Four kinds of hypotypes have nothing in common with each other clinic and
Epidemiologic feature.I types and the most typical Clinical symptoms of II types are to cause children's laryngotracheobronchitis, and I types are this children
The main reason for laryngotracheobronchitis, II types take second place.I types and II types can cause the other upper respiratory tract and lower respiratory tract diseases
Disease.Type III frequently results in pneumonia and capillary bronchitis.IV types are difficult detection, it may be possible to because it seldom causes serious disease.
The incubation period of human parainfluenza virus is typically at 1~7 day or so.
Rapid&Early diagnosis parainfluenza virus infection can guiding clinical treatment be in time reasonable selection antiviral antibacterial
Medicine offer foundation is simultaneously significant in terms of abuse of antibiotics is prevented.
The method of detection parainfluenza virus is more at present, but all Shortcomings, such as Electronic Speculum detection method complex and expensive, virus
It is separately cultured time-consuming extremely length and false negative is more, clinical meaning, ELISA inspection has generally been lost after cultivation results are taken
That surveys is special viral antibody but is once only capable of detecting a kind of virus.And the detection of nucleic acids based on nucleic acid amplification, due to speed
Hurry up and (can complete to detect in usual 3 hours), high sensitivity, specificity it is good, be increasingly becoming goldstandard in field of virus detection.
The amplification technique (Nucleic Acid Sequence Based Amplification) of nucleotide sequence is relied on, i.e.,
NASBA amplification techniques, it is to be mediated by pair of primers, be specific in vitro and continuous homogeneous to single stranded RNA progress constant temperature expansion
The process of increasing.Under 41 DEG C of constant temperatures, in terms of reaction speed, template ribonucleic acid can be expanded about 10 by NASBA amplifications 1h9~1012
Times, and common PCR reactions need 2~3h.In terms of detection sensitivity, NASBA, which can be detected, is less than 10gene in solution
Copies/ μ l trace target, and PCR test limit is in 100gene copies/ μ l or so.Therefore, NASBA technologies are either
Amplification efficiency or detection sensitivity are all higher than RT-PCR technology.And because NASBA reaction only needs one 41 DEG C of perseverance
Warm condition, water-bath can meet that reaction requires, it is not necessary to the temperature control device that the Standard PCR such as complicated heating and cooling is relied on, because
The instrument cost of this NASBA technology is very cheap.Combined with corresponding detection technique, NASBA also has easy to operate, specific
Many advantages, such as strong.
The content of the invention
First purpose of the present invention is to provide a kind of primer pair group for being used to detect parainfluenza virus.
The primer pair group provided by the present invention for being used to detect parainfluenza virus, is made up of following 3 primer pairs:
The primer pair 1 being made up of two single strand dnas shown in sequence in sequence table 1 and sequence 2;By sequence in sequence table
The primer pair 2 of two single strand dnas composition shown in row 3 and sequence 4;As two shown in sequence in sequence table 5 and sequence 6
The primer pair 3 of single strand dna composition.
Wherein, the primer pair 1 (PIV1) is used to expand parainfluenza virus I types;The primer pair 2 (PIV2) is used to expand
Parainfluenza virus II types;The primer pair 3 (PIV3) is used to expand parainfluenza virus type III.
Second object of the present invention is to provide a kind of complete single stranded DNA for being used to detect parainfluenza virus.
The complete single stranded DNA provided by the present invention for being used to detect parainfluenza virus, by probe groups and the primer pair group
Composition;The probe groups are made up of following 3 ssDNA probes:SsDNA probe 1 in sequence table shown in sequence 7;Sequence
SsDNA probe 2 in table shown in sequence 8;SsDNA probe 3 in sequence table shown in sequence 9.
Wherein, the ssDNA probe 1 (PIV1_TY_MB) is used for the amplification for monitoring the primer pair 1 in real time;Institute
State the amplification that ssDNA probe 2 (PIV2_TY_MB) is used to monitor the primer pair 2 in real time;The ssDNA probe 3
(PIV3_TY_MB) it is used for the amplification for monitoring the primer pair 3 in real time.
5 ' the ends mark of every ssDNA probe in the probe groups has FAM, and 3 ' ends mark
There is fluorescent quenching group TAMRA.
In the complete single stranded DNA provided by the present invention, each primer pair and its corresponding ssDNA probe can be single
Solely it is packaged in a packaging.As the primer pair 1 and the ssDNA probe 1 are packaged in first packaging;The primer
2 and the ssDNA probe 2 are packaged in second packaging;The primer pair 3 and the ssDNA probe 3 are packaged in
In three packagings.
Third object of the present invention is to provide a kind of kit for being used to detect parainfluenza virus.
The kit provided by the present invention for being used to detect parainfluenza virus, contains the primer pair group or the complete list
Chain DNA.
The kit can also contain internal reference primer pair and internal reference probe.The internal reference primer pair is for expanding
House-keeping gene GAPDH mRNA primer pair GAPD_IC in human genome, as two shown in sequence in sequence table 10 and sequence 11
Bar single strand dna forms.The internal reference probe (GAPD_IC_MB) is that the single stranded DNA in sequence table shown in sequence 12 is visited
Pin, for monitoring the amplification of the internal reference primer pair (GAPD_IC) in real time.
5 ' ends of the internal reference probe are marked with fluorescent reporter group FAM, and 3 ' ends are marked with fluorescent quenching group
TAMRA。
Constant-temperature amplification buffer solution and constant-temperature amplification enzyme solutions can also be contained in the kit.
The solvent of the constant-temperature amplification buffer solution is water, and solute and concentration are as follows:200mM pH 8.0 Tris-HCL,
50mM DTT, 10mM dNTP, 10mM rNTP, 80mM MgCl2, 450mM KCl, 15% volumn concentration DMSO, 1M sorb
Alcohol, 20mM tetramethyl ammonium chlorides.
The solvent of the constant-temperature amplification enzyme solutions is water, and solute and concentration are as follows:AMV reverse transcriptase 1U/ μ l, T7RNA gather
Synthase 5U/ μ l, ribonuclease H 0.5U/ μ l, pyrophosphatase 0.5U/ μ l, RNase inhibitor 5U/ μ l, BSA0.5 μ g/ μ l.
Dish-style chip can also be contained in the kit, such as 24 reaction chamber dish-style chips.
In the present invention, the 24 reaction chamber dish-style chip is " the brilliant core of Capitalbio Corporation Co., Ltd.'s production
The supporting dish-style chip of RTisochipTM-A constant-temperature amplification micro-fluidic chips nucleic acids instrument ", its model 1 × 24.
The 1# of the dish-style chip deposits dry following (1)-(5) to 5# reaction chambers respectively:
(1) primer pair 1 and the ssDNA probe 1;(2) primer pair 2 and the ssDNA probe 2;(3)
The primer pair 3 and the ssDNA probe 3;(4) the internal reference primer pair and the internal reference probe;(5) negative control
Product.
The negative controls concretely water without RNase (Rnase-free water).
Wherein, the method for primer and probe being embedded into dish-style chip is:By primer, the spy corresponding with the primer
Pin, agarose mixing, are configured to mixed solution, make the primer, the probe and the agarose in the mixed solution
Final concentration be respectively 0.2 μM, 50nM, 0.1% (weight/mass percentage composition);Mixed solution described in 1 μ l is taken to click and enter corresponding dish-style
Chip reaction chamber, after being dried in clean super-clean bench, tabletting encapsulation, punching press is made after vacuumizing.
The primer pair group or complete single stranded DNA or kit are non-diagnostic in detecting or aiding in detection parainfluenza virus
Purpose application falls within protection scope of the present invention.
In the application, by constant-temperature amplification enzyme solutions described in constant-temperature amplification buffer solution described in 15 μ l and 10 μ l, with 25 μ l
It is injected into after the mixing of sample to be tested solution in the dish-style chip, isothermal reaction 1h at 41 DEG C.
In the application, sample to be tested can be used as using Nasopharyngeal swabs;Accordingly, the sample to be tested solution can be from nose
The RNA extracted in throat swab.
In the present invention, the parainfluenza virus is concretely at least one of following:Parainfluenza virus I types, sidestream
Influenza Virus II types and parainfluenza virus type III.
Kit provided by the invention supports high flux, parainfluenza virus infection can be quickly and accurately detected, for clinic
For, the testing result that 3 kinds of parainfluenza virus indexs can be obtained in 1 hour is not only faster than the reality more generally used at present
When fluorescence quantifying PCR method, and for quick auxiliary direction treatment and medication it is also significant.Meanwhile multi objective
Detection can be used for regional epidemiological survey and epidemic situation monitoring, to study prevalence of the parainfluenza virus infection in China
Situation.
Brief description of the drawings
Fig. 1 is dish-style chip and primer sample application cavity schematic diagram.
Fig. 2 is 3 kinds of parainfluenza virus reference material dish-style chip testing result figures.Wherein, A is to contain parainfluenza virus I types
Testing results of the recombinant plasmid pUC19-PIV1 of target gene in 1# reaction chambers;B is to contain parainfluenza virus II type target bases
Testing results of the recombinant plasmid pUC19-PIV2 of cause in 2# reaction chambers;C is the weight containing parainfluenza virus type III target gene
Testing results of the group plasmid pUC19-PIV3 in 3# reaction chambers.In A-C, E1 represents that template is 101Copy/μ l, by that analogy, E5
It is 10 to represent template5Copy/μ l;NC represents negative control.
Embodiment
Experimental method used in following embodiments is conventional method unless otherwise specified.
Material used, reagent etc., unless otherwise specified, are commercially obtained in following embodiments.
The preparation and its use of embodiment 1, kit for detecting parainfluenza virus
First, for the preparation for the kit for detecting parainfluenza virus
Kit forms provided by the present invention for detecting parainfluenza virus are as follows:
1st, constant-temperature amplification buffer solution
The solvent of constant-temperature amplification buffer solution is water, and solute and concentration are as follows:200mM Tris-HCL (pH 8.0), 50mM
DTT, 10mM dNTP, 10mM rNTP, 80mM MgCl2, 450mM KCl, 15% volumn concentration DMSO, 1M sorbierite,
20mM tetramethyl ammonium chlorides.
2nd, constant-temperature amplification enzyme solutions
The solvent of constant-temperature amplification enzyme solutions is water, and solute and concentration are as follows:AMV reverse transcriptase 1U/ μ l, t7 rna polymerase
5U/ μ l, ribonuclease H 0.5U/ μ l, the μ g/ μ l of pyrophosphatase 0.5U/ μ l, RNase inhibitor 5U/ μ l, BSA 0.5.
3rd, 24 reaction chamber dish-style chips of primer pair and ssDNA probe are mounted with
The 24 reaction chamber dish-style chip is " the brilliant core RTisochipTM-A perseverances of Capitalbio Corporation Co., Ltd.'s production
The supporting dish-style chip of temperature amplification micro-fluidic chip nucleic acids instrument ", its model 1 × 24, schematic diagram is as shown in Figure 1.
The 1# of the 24 reaction chamber dish-style chip deposits dry following (1)-(5) to 5# reaction chambers respectively:
(1) primer pair 1 and ssDNA probe 1;(2) primer pair 2 and ssDNA probe 2;(3) primer pair 3 and single stranded DNA
Probe 3;(4) internal reference primer pair and internal reference probe;(5) negative controls.The negative controls are specially without RNase
Water (Rnase-free water).
Wherein, the primer pair 1 (PIV1) is used to expand parainfluenza virus I types, by sequence in sequence table 1 and the institute of sequence 2
The two single strand dnas composition shown;The primer pair 2 (PIV2) is used to expand parainfluenza virus II types, by sequence in sequence table
Two single strand dnas composition shown in row 3 and sequence 4;The primer pair 3 (PIV3) is used to expand parainfluenza virus type III,
It is made up of two single strand dnas shown in sequence in sequence table 5 and sequence 6.The internal reference primer pair (GAPD_IC) is used for
House-keeping gene GAPDH mRNA in human genome are expanded, as two single stranded DNAs shown in sequence in sequence table 10 and sequence 11 point
Son composition.
The ssDNA probe 1 (PIV1_TY_MB) is used for the amplification for monitoring the primer pair 1 in real time, its nucleosides
Acid sequence is sequence 7 in sequence table;The ssDNA probe 2 (PIV2TY MB) is used for the expansion for monitoring the primer pair 2 in real time
Increase result, its nucleotides sequence is classified as sequence 8 in sequence table;The ssDNA probe 3 (PIV3_TY_MB) is used to monitor institute in real time
The amplification of primer pair 3 is stated, its nucleotides sequence is classified as sequence 9 in sequence table.The internal reference probe (GAPD_IC_MB) is used
In the amplification for monitoring the internal reference primer pair (GAPD_IC) in real time, its nucleotides sequence is classified as sequence 12 in sequence table.Often
5 ' the ends mark of ssDNA probe described in bar and the internal reference probe (GAPD_IC_MB) has FAM,
3 ' ends mark has TAMRA.
Wherein, the method for primer and probe being embedded into dish-style chip is:By primer, the spy corresponding with the primer
Pin, agarose mixing, are configured to mixed solution, make the primer, the probe and the agarose in the mixed solution
Final concentration be respectively 0.2 μM, 50nM, 0.1% (weight/mass percentage composition);Mixed solution described in 1 μ l is taken to click and enter corresponding dish-style
Chip reaction chamber, after being dried in clean super-clean bench, tabletting encapsulation, punching press is made after vacuumizing.
2nd, for the application method for the kit for detecting parainfluenza virus
1st, reaction system is prepared
15 μ l constant-temperature amplifications buffer solutions (see step 1 1), 10 μ l constant-temperature amplifications enzyme solutions (see step 1 2), 25 μ l are taken to treat
This liquid of test sample is mixed into 50 μ l reaction solutions, after vortex concussion uniformly injection be mounted with primer pair and the 24 of ssDNA probe anti-
Chamber dish-style chip (see step 1 3) is answered, seals Quick spin 30s after membrana oralis.
2nd, isothermal amplification reactions and detection
Dish-style chip is placed in rich Isochip-RT constant-temperature amplifications instrument difficult to understand, sets 41 DEG C to react 1 hour, and complete simultaneously
Real-time fluorescence scans.
3rd, result judges
After reaction terminates, according to the amplification curve of sample in each reaction chamber, the sample to be tested is determined as follows
Whether the genome of corresponding parainfluenza virus is contained in liquid:If the testing sample produces S type amplification curves, described to treat test sample
Contain the genome of corresponding parainfluenza virus in this liquid;Conversely, then corresponding parainfluenza virus is not contained in the sample to be tested liquid
Genome.
Embodiment 2, the analysis of the sensitivity and specificity of kit for detecting parainfluenza virus
First, the preparation of reference material RNA nucleic acid
1st, structure includes the plasmid of parainfluenza virus target gene
(1) plasmid containing parainfluenza virus I type target genes
By 464~1296 sections (the parainfluenza virus I type target gene sequences of parainfluenza virus I type target gene sequences
Genbank Sequence ID:Gb | JF416791.1 |, Update Date:2014-12-31) it is inserted into pUC19 carriers
Between the multiple cloning sites EcoR V of (day is with biochemical corp's product).Obtain recombinant plasmid pUC19-PIV1.
(2) plasmid containing parainfluenza virus II type target genes
By 2568~3629 sections (the parainfluenza virus II type target gene sequences of parainfluenza virus II type target gene sequences
The Genbank Sequence ID of row:Gb | DQ072586.1 |, Update Date:2008-9-4) it is inserted into pUC19 carriers
Between the multiple cloning sites EcoR V of (day is with biochemical corp's product).Obtain recombinant plasmid pUC19-PIV2.
(3) plasmid containing parainfluenza virus type III target gene
By 211~1190 sections (the parainfluenza virus type III target gene of parainfluenza virus type III target gene sequence
The Genbank Sequence ID of sequence:Dbj | AB623488.1 |, Update Date:2014-7-26) it is inserted into pUC19
Between the multiple cloning sites EcoR V of carrier (day is with biochemical corp's product).Obtain recombinant plasmid pUC19-PIV3.
2nd, the preparation of reference material RNA nucleic acid
For trying recombinant plasmid:3 kinds of recombinant plasmids for containing corresponding parainfluenza virus target gene that step 1 is built.
(1) digestion:First 37 DEG C of digestion 2h of EcoRI restriction endonucleases are used by each for examination recombinant plasmid.
(2) transcribe:It polymerize by 5 μ l 5 × Transcription Optimized Buffer (Promega), 2U T7RNA
Enzyme, 10mM DTT (Promega), 10U recombinant RNAs enzyme inhibitor (Promega), 2mM rNTP, the μ l of digestion products 5 prepare overall
Product is 50 μ l reaction system, 37 DEG C of transcription 4h after shaking uniformly.
(3) digest:System after the completion of transcription is added to 1 μ l DNA digestive ferments (rDnaseI, 5U/ μ l), concussion centrifuges,
37 DEG C of incubation 20min.
(4) purify:Using the RNA purification kits products of Macherey-Nagel companies, (its catalog number is
740948) transcription product RNA is purified as follows:A) RA1-C is prepared2H5OH mixed liquors:With RA1:C2H5OH=1:1 (volume
Than) ratio prepare., it is necessary to add 600 μ l RA1-C in every 100 μ l transcription product2H5OH mixed liquors, i.e. 300 μ l RA1+
300μl C2H5OH solution, need to calculate the volume for matching somebody with somebody mixed liquor according to the pipe number of transcription product herein.If product is insufficient
100 μ l, then the amount of product is mended to 100 μ l with water and (50 μ l Tiangeng Rnase-free H are added in every pipe product2O)。
B) the ready RA1-C by before2H5OH mixed liquors are assigned in 1.5ml centrifuge tubes, two pipes, often the μ l of pipe 600, and 100 μ l products are turned
Enter into corresponding centrifuge tube, totally 700 μ l, fully shaking centrifuge in pipe.C) prepare two adsorption columns, and carry out corresponding mark
Note, 700 μ l product mixtures are transferred in adsorption column (adsorption column maximum capacity is 700 μ l), 1.2 ten thousand rpm centrifugation 2min, are fallen
Fall down a layer solution.D) 700 μ l RA3 is added in adsorption column, 1min is placed, it is sufficiently dispersed in the bottom of adsorption column
Portion, 1.2 ten thousand rpm centrifugation 2min, outwells lower floor's solution.E) 350 μ l RA3 is added in adsorption column, places 2min, 1.2 ten thousand rpm
2min is centrifuged, outwells lower floor's solution.F) 300 μ l RA3 is added in adsorption column, 2min is placed, 1.2 ten thousand rpm centrifugation 2min, falls
Fall down a layer solution.G) after the lid 3min for opening adsorption column, 1.2 ten thousand rpm skies outwell lower floor's solution, repeat this step from 2min
Once.H) it is empty from end after, adsorption column is transferred in corresponding centrifuge tube, opens adsorption column lid and place 15min, make
Ethanol volatilization is complete, and 60 μ l Rnase-H are added in adsorption column2O (carries) elution in kit, place 2min, and 1.2 ten thousand
Rpm centrifuges 2min.I) centrifugation gained template is sucked back in adsorption column, places 2min, 1.2 ten thousand rpm centrifugation 2min, repeat this step
Twice.J) adsorption column is lost, the template in centrifuge tube is taken out into 2 μ l, determines its concentration with Nano drop, and record its concentration
And its 260/280,260/230 ratio.
2nd, for the sensitivity and specificity analysis for the kit for detecting parainfluenza virus
1st, prepared by the reference material template of various concentrations
It is fixed that each RNA templates (the 3 kinds of recombinant plasmids built in corresponding step 1 1) of above-mentioned steps one after purification are calculated
Measure to 1010Copy/μ l, and gradient dilution, obtain 105Copy/μ l, 104Copy/μ l, 103Copy/μ l, 102Copy/μ l, 10 are copied
The template dilution of the various concentrations such as shellfish/μ l.
2nd, reaction system is prepared
15 μ l constant-temperature amplifications buffer solutions are taken (see the step 1) of embodiment 1,10 μ l constant-temperature amplifications enzyme solutions (see the step of embodiment 1
2), the template dilution of 25 μ l concentration is mixed into 50 μ l reaction solutions, after vortex concussion uniformly injection be mounted with primer pair and
24 reaction chamber dish-style chips of ssDNA probe (see the step 3) of embodiment 1, seal Quick spin 30s after membrana oralis.
3rd, isothermal amplification reactions and detection
Dish-style chip is placed in rich Isochip-RT constant-temperature amplifications instrument difficult to understand, sets 41 DEG C to react 1 hour, and complete simultaneously
Real-time fluorescence scans.And result is judged according to the method for the step 23 of embodiment 1.
3rd, result
As a result it is as shown in Figure 2:
(1) for recombinant plasmid pUC19-PIV1 RNA sample, the 1# reaction chambers pair of 24 reaction chamber dish-style chips
105Copy/μ l, 104Copy/μ l, 103Copy/μ l, 102The testing result of copy/μ l, 10 copies/μ l templates has obvious S
Type amplification curve, it is shown as positive;And 2# and 3# reaction chambers are shown as negative without amplification curve.
(2) for recombinant plasmid pUC19-PIV2 RNA sample, the 2# reaction chambers pair of 24 reaction chamber dish-style chips
105Copy/μ l, 104Copy/μ l, 103Copy/μ l, 102The testing result of copy/μ l, 10 copies/μ l templates has obvious S
Type amplification curve, it is shown as positive;And 1# and 3# reaction chambers are shown as negative without amplification curve.
(3) for recombinant plasmid pUC19-PIV3 RNA sample, the 3# reaction chambers pair of 24 reaction chamber dish-style chips
105Copy/μ l, 104Copy/μ l, 103Copy/μ l, 102The testing result of copy/μ l, 10 copies/μ l templates has obvious S
Type amplification curve, it is shown as positive;And 1# and 2# reaction chambers are shown as negative without amplification curve.
In addition, for the RNA sample of 3 kinds of all recombinant plasmids, the 4# reaction chambers of 24 reaction chamber dish-style chips are (interior
Control) and 5# reaction chambers (negative control) without amplification curve.4# reaction chambers (internal reference) why without amplification curve be because
Sample to be tested is the RNA nucleic acid of 3 kinds of recombinant plasmids, does not contain the RNA of house-keeping gene GAPDH in human genome.
It these results suggest that the kit has higher amplification sensitivity and specific amplification.
The detection of embodiment 3, actual clinical sample
First, clinical sample type
The present embodiment use clinical sample from Shenzhen San Yuan in collection Nasopharyngeal swabs sample (in line with this picker from
The principle of hope), adopt swab and deposit in 3mL physiological saline, totally 560.
2nd, in clinical sample viral nucleic acid extraction
Clinical sample viral nucleic acid extraction kit used is QIAamp Viral RNA Mini Kit (Qiagen),
Extracted as follows:
(1) take and the μ l of physiological saline 140 of clinical sample swab are deposited in step 1 in 1.5ml centrifuge tubes;
(2) Buffer AVL (the i.e. 5.6 μ l Carrier RNA mixing that 560 μ l contain Carrier RNA mixed liquors is added
The μ l Buffer of liquid+560 AVL are in centrifuge tube, slight whirlpool 15s;
(3) after the completion of brief centrifugation, (15-25 DEG C) placement 10-20min of room temperature, to ensure Buffer AVL in centrifuge tube
In have abundance time cracked;
(4) 560 μ l ethanol (96-100%, volumn concentration) are added in centrifuge tube, whirlpool mixes 15s, centrifugation;
(5) 630 μ l sample solutions are taken in adsorption column, 2min is placed, it is fully contacted with adsorption column, 8000rpm, from
Heart 1min, change clean collecting pipe;
(6) if sample solution is more than 630 μ l, repeatedly previous step;
(7) 500 μ l AW1 washing lotions are added in adsorption column, 2min is placed, it is fully contacted with adsorption column, 8000rpm
1min is centrifuged, changes clean collecting pipe;
(8) 500 μ l AW2 washing lotions are added in adsorption column, 2min is placed, it is fully contacted with adsorption column,
12000rpm centrifuges 3min, changes clean collecting pipe;
(9) 300 μ l AW2 washing lotions are added in adsorption column, 2min is placed, it is fully contacted with adsorption column,
12000rpm centrifuges 3min, changes clean collecting pipe;
(10) adsorption column lid is opened and places 2min, make that its inside and outside pressure is consistent, and 8000rpm skies are from 1min.It is empty from knot
Shu Yihou, repeat this step once.
(11) it is empty from end after, adsorption column is transferred in 1.5ml centrifuge tubes, open adsorption column lid, place 20-30min,
Make ethanol volatilization complete;
(12) 50 μ l Buffer AVE elution nucleic acid, 8000rpm centrifugation 1min, after centrifugation is completed, by under elution are added
Nucleic acid suck back adsorption column, lose adsorption column after centrifuging 1min.
3rd, the detection of actual clinical sample
1st, reaction system is prepared
15 μ l constant-temperature amplifications buffer solutions (see the step 11 of embodiment 1), 10 μ l constant-temperature amplifications enzyme solutions are taken (see the step of embodiment 1
Rapid 1 2), the clinical sample solution that 25 μ l step 2 are extracted to obtain is mixed into 50 μ l reaction solutions, is injected after vortex concussion uniformly
It is mounted with the 24 reaction chamber dish-style chips (see the step 13 of embodiment 1) of primer pair and ssDNA probe, seals rapid after membrana oralis
Centrifuge 30s.
2nd, isothermal amplification reactions and detection
Dish-style chip is placed in rich Isochip-RT constant-temperature amplifications instrument difficult to understand, sets 41 DEG C to react 1 hour, and complete simultaneously
Real-time fluorescence scans.And result is judged according to the method for the step 23 of embodiment 1.
Experiment sets reliability demonstration of the conventional RT-PCR method for kit testing result of the present invention simultaneously.For examining
It is as shown in table 1 to survey each viral specific RT-PCR primer sequence.
Table 1 is used for the specific RT-PCR primer sequence for detecting 3 kinds of parainfluenza viruses
Index name | RT-PCR sense primers (5 ' -3 ') | RT-PCR anti-sense primers (5 ' -3 ') |
Parainfluenza virus I types | GTAGTCTCATTCACAGTGGGYAAGGA | ATCTCATTATTACCYGGACCAAGTCT |
Parainfluenza virus II types | TACAAGACACAACCTCCTGGTATAGCA | GGACGCCTAAATATGGACCTCTCCT |
Parainfluenza virus type III | TCTCTCTGTGTTTTCCCVGGACACCC | GACTTAAATCCYAGGATCTCTCATAC |
4th, result
The testing result of kit of the present invention is shown, for each parainfluenza virus, sun is detected using RT-PCR method
Property sample example using kit of the present invention detection show positive findings.In addition, for a few sample example, using RT-
The detection of PCR methods is negative, but uses kit testing result of the present invention as the positive.Adopted again by the way that these sample examples are carried out with the later stage
Sample RT-PCR is detected, it is found that it is positive these sample examples are detected as corresponding parainfluenza virus really.It is indicated above, kit of the present invention
RT-PCR methods are higher than to the recall rate of corresponding parainfluenza virus, and its testing result is accurately and reliably.Kit and RT- of the present invention
The statistical result of PCR methods detection parainfluenza virus clinical sample is referring to table 2.
The statistical result of 2 kit of the present invention of table and RT-PCR methods detection parainfluenza virus clinical sample
Claims (3)
1. the kit for detecting parainfluenza virus, contains probe groups and primer pair group;
The primer pair group, it is made up of following 3 primer pairs:Sequence 1 and the primer pair 1 shown in sequence 2 in sequence table;Sequence table
Primer pair 2 shown in middle sequence 3 and sequence 4;Sequence 5 and the primer pair 3 shown in sequence 6 in sequence table;
The probe groups are made up of following 3 probes:Probe 1 in sequence table shown in sequence 7;In sequence table shown in sequence 8
Probe 2;Probe 3 in sequence table shown in sequence 9;
5 ' the ends mark of each probe in the probe groups has FAM, and 3 ' ends mark has
Group TAMRA;
The kit also contains internal reference primer pair and internal reference probe;Sequence 10 in the internal reference primer pair such as sequence table
Shown in sequence 11;The internal reference probe is the probe shown in sequence 12 in sequence table;5 ' end marks of the internal reference probe
Note has fluorescent reporter group FAM, and 3 ' ends are marked with fluorescent quenching group TAMRA;
Also contain dish-style chip in the kit;
The 1# of the dish-style chip deposits dry as follows respectively to 5# reaction chambers(1)-(5):
(1)The primer pair 1 and the probe 1;
(2)The primer pair 2 and the probe 2;
(3)The primer pair 3 and the probe 3;
(4)The internal reference primer pair and the internal reference probe;
(5)Negative controls;
The dish-style chip is 24 reaction chamber dish-style chips.
2. kit according to claim 1, it is characterised in that:In the kit also containing constant-temperature amplification buffer solution and
Constant-temperature amplification enzyme solutions;
The solvent of the constant-temperature amplification buffer solution is water, and solute and concentration are as follows:200mM pH 8.0 Tris-HCL, 50mM
DTT, 10mM dNTP, 10mM rNTP, 80mM MgCl2, 450mM KCl, 15% volumn concentration DMSO, 1M sorbierite,
20mM tetramethyl ammonium chlorides;
The solvent of the constant-temperature amplification enzyme solutions is water, and solute and concentration are as follows:AMV reverse transcriptase 1U/ μ l, T7 RNA polymerize
Enzyme 5U/ μ l, ribonuclease H 0.5U/ μ l, the μ g/ μ l of pyrophosphatase 0.5U/ μ l, RNase inhibitor 5U/ μ l, BSA 0.5.
3. kit according to claim 1 or 2, it is characterised in that:The parainfluenza virus is at least one in following
Kind:Parainfluenza virus I types, parainfluenza virus II types and parainfluenza virus type III.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510468275.2A CN105039596B (en) | 2015-08-03 | 2015-08-03 | A kind of kit and its application for being used to detect parainfluenza virus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510468275.2A CN105039596B (en) | 2015-08-03 | 2015-08-03 | A kind of kit and its application for being used to detect parainfluenza virus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105039596A CN105039596A (en) | 2015-11-11 |
CN105039596B true CN105039596B (en) | 2017-11-10 |
Family
ID=54446562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510468275.2A Active CN105039596B (en) | 2015-08-03 | 2015-08-03 | A kind of kit and its application for being used to detect parainfluenza virus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105039596B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109207640B (en) * | 2018-10-23 | 2023-06-02 | 深圳市亿立方生物技术有限公司 | Primer group, probe group and kit for detecting various respiratory viruses and application of primer group, probe group and kit |
CN111621585B (en) * | 2020-04-16 | 2021-03-02 | 大连民族大学 | Rapid detection kit for simultaneously detecting multiple transgenic rape lines and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101545015A (en) * | 2009-05-11 | 2009-09-30 | 北京海康基因芯片开发有限公司 | Method for detecting infectious disease pathogens and kit |
CN103831140A (en) * | 2014-03-07 | 2014-06-04 | 博奥生物集团有限公司 | Micro-fluidic chip for multi-index detection |
CN103993104A (en) * | 2014-05-27 | 2014-08-20 | 福建省立医院 | Primer group and probe group for detecting acute respiratory infectious diseases as well as application method and kit thereof |
-
2015
- 2015-08-03 CN CN201510468275.2A patent/CN105039596B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101545015A (en) * | 2009-05-11 | 2009-09-30 | 北京海康基因芯片开发有限公司 | Method for detecting infectious disease pathogens and kit |
CN103831140A (en) * | 2014-03-07 | 2014-06-04 | 博奥生物集团有限公司 | Micro-fluidic chip for multi-index detection |
CN103993104A (en) * | 2014-05-27 | 2014-08-20 | 福建省立医院 | Primer group and probe group for detecting acute respiratory infectious diseases as well as application method and kit thereof |
Non-Patent Citations (2)
Title |
---|
Pyrosequencing on templates generated by asymmetric nucleic acid sequence-based amplification (asymmetric-NASBA);Huning Jia, et al;《Analyst》;20111231;第136卷;5229–5233 * |
Sam Hibbitts,et al.Development and evaluation of NucliSens†Basic Kit NASBA for diagnosis of parainfluenza virus infection with ‘end-point’ and ‘realtime"detetion.《Journal of Virological Methods》.2003,第108卷145-155. * |
Also Published As
Publication number | Publication date |
---|---|
CN105039596A (en) | 2015-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105018648B (en) | A kind of kit and its application for being used to detect Respirovirus | |
CN105112559B (en) | A kind of kit and its application for being used to detect coronavirus | |
CN105039597B (en) | A kind of kit and its application for being used to detect influenza virus | |
CN111778357B (en) | CRISPR/Cas12 a-based respiratory syncytial virus nucleic acid rapid detection kit and detection method thereof | |
CN109576352A (en) | Single tube detects method, probe and its kit of multiple object to be measured nucleic acid sequences | |
WO2022057060A1 (en) | Method and kit for multiple detection of respiratory virus nucleic acids | |
CN105018488B (en) | Kit and its application for detecting Respirovirus | |
CN106521032B (en) | A kind of nucleic acid amplification technologies and its application in carapuru virus detection | |
CN105400907A (en) | Kit for nucleic acid combined detection of influenza virus A, influenza virus B and respiratory syncytial virus | |
CN101942525B (en) | One-tube method with multiplex detection for human Influenza A and B and new Influenza A H1N1 virus and kit | |
CN101948931A (en) | Single-tube multiplex fluorescence PCR (Polymerase Chain Reaction) detection method and kit for 1,2,3-type parainfluenza viruses | |
CN112359145A (en) | Multiple primers and kit for rapidly detecting influenza A, influenza B and novel coronavirus | |
CN103074449A (en) | Kit for synchronously detecting thirteen diarrhea viruses and detection method of kit | |
CN105543414A (en) | Respiratory syncytial virus A/B subtype multiplex fluorescence quantitative PCR detection primer set and probe set and reagent kit and preparation method thereof | |
CN107488748A (en) | A kind of composition, kit and its detection method for being used to detect 23 kinds of respiratory pathogens | |
WO2023109031A1 (en) | Respiratory pathogen detection kit, and preparation method therefor and use thereof | |
CN105112407B (en) | A kind of kit and its application for being used to detect enterovirus | |
CN105039596B (en) | A kind of kit and its application for being used to detect parainfluenza virus | |
CN103966356A (en) | Human immunodeficiency virus type 1 one-step fluorescence quantitative RT-PCR detection kit | |
CN107574262A (en) | A kind of fluorescence RT RAA primers, probe and detection method for being used to detect A (H 1 N 1) virus | |
CN108239676A (en) | A kind of parainfluenza virus one-step method fluorescence parting RT-PCR detection kit | |
CN107083446A (en) | Diarrhoea pathogenic bacteria multiple gene detection architecture and its kit and application | |
EP4163397A1 (en) | Specimen transport kit for detecting respiratory pathogens and methods for detecting respiratory pathogens using same | |
CN105936945B (en) | A kind of multiple reverse transcription quantitative PCR kit of four kinds of Respirovirus of joint inspection | |
CN106521035B (en) | Gene chip detection kit and method for detecting 16 respiratory pathogens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |